患有指端溃疡的系统性硬化症患者迎来新希望。 - Suppr

Suppr

超能文献

New hope for systemic sclerosis patients with digital ulcers.

作者信息

Varga John

出版信息

Curr Rheumatol Rep. 2005 Apr;7(2):127-8. doi: 10.1007/s11926-005-0064-1.

DOI:10.1007/s11926-005-0064-1

PMID:15760591

Abstract

摘要

相似文献

New hope for systemic sclerosis patients with digital ulcers.

Curr Rheumatol Rep. 2005 Apr;7(2):127-8. doi: 10.1007/s11926-005-0064-1.

Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial.

Ann Rheum Dis. 2011 Jan;70(1):32-8. doi: 10.1136/ard.2010.130658. Epub 2010 Aug 30.

Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.

Arthritis Rheum. 2004 Dec;50(12):3985-93. doi: 10.1002/art.20676.

Bosentan: a review of its use in the management of digital ulcers associated with systemic sclerosis.

Drugs. 2009 Oct 1;69(14):2005-24. doi: 10.2165/10489160-000000000-00000.

Connective tissue diseases: Treatment of digital ulcers in systemic sclerosis.

Nat Rev Rheumatol. 2011 Jan;7(1):5-6. doi: 10.1038/nrrheum.2010.207. Epub 2010 Nov 30.

Bosentan for digital ulcers prevention does not worsen cardiopulmonary exercise test parameters in SSc patients with interstitial lung disease.

Int J Cardiol. 2016 Nov 15;223:113-115. doi: 10.1016/j.ijcard.2016.08.095. Epub 2016 Aug 6.

Safety and tolerability of bosentan for digital ulcers in Japanese patients with systemic sclerosis: Prospective, multicenter, open-label study.

J Dermatol. 2017 Jan;44(1):13-17. doi: 10.1111/1346-8138.13497. Epub 2016 Jul 4.

Successful treatment of systemic sclerosis digital ulcers and pulmonary arterial hypertension with endothelin receptor antagonist bosentan.

Rheumatology (Oxford). 2003 Jan;42(1):191-3. doi: 10.1093/rheumatology/keg050.

Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis: DUAL-1 and DUAL-2 Randomized Clinical Trials.

JAMA. 2016 May 10;315(18):1975-88. doi: 10.1001/jama.2016.5258.

In systemic sclerosis patients, bosentan is safe and effective for digital ulcer prevention and it seems to attenuate the development of pulmonary arterial hypertension.

Rheumatology (Oxford). 2014 Mar;53(3):570-1. doi: 10.1093/rheumatology/ket424. Epub 2013 Dec 18.

引用本文的文献

The diagnosis and treatment of Raynaud's phenomenon: a practical approach.

Drugs. 2007;67(4):517-25. doi: 10.2165/00003495-200767040-00003.

本文引用的文献

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.

Ann Intern Med. 2000 Mar 21;132(6):425-34. doi: 10.7326/0003-4819-132-6-200003210-00002.

Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.

J Rheumatol. 1992 Sep;19(9):1407-14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验